Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
Life Sci
    April 2026
  1. BARTOLOMEO CS, Lemes RMR, Morais RL, Pereria GC, et al
    Corrigendum to "SARS-CoV-2 infection and replication kinetics in different human cell types: The role of autophagy, cellular metabolism and ACE2 expression" [Life Sciences 308 (2022) 120930].
    Life Sci. 2026 Apr 9:124367. doi: 10.1016/j.lfs.2026.124367.
    >> Share

    March 2026
  2. CHEN W, Ji MC, Jung E, Shin JS, et al
    Broad-spectrum coronavirus inhibition by RSV fusion inhibitors targeting six-helix bundle formation.
    Life Sci. 2026 Mar 31:124357. doi: 10.1016/j.lfs.2026.124357.
    >> Share

    April 2025
  3. AZEEM M, Cancemi P, Mukhtar F, Marino S, et al
    Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review.
    Life Sci. 2025;371:123610.
    >> Share

    March 2025
  4. DUERR GD, Hamiko M, Beer J, Nattermann J, et al
    The interplay between COVID-19 and heart disease: Unravelling a complex connection.
    Life Sci. 2025 Mar 3:123524. doi: 10.1016/j.lfs.2025.123524.
    >> Share

    January 2025
  5. DE SOUZA ALG, da Silva Rosa Alves AL, de Sousa JC, Barbosa NC, et al
    Inactivated SARS-CoV-2 induces acute skeletal muscle damage in human K18-hACE2 transgenic mice.
    Life Sci. 2025 Jan 18:123404. doi: 10.1016/j.lfs.2025.123404.
    >> Share

  6. SHAFQAT A, Li M, Zakirullah, Liu F, et al
    A comprehensive review of research advances in the study of lactoferrin to treat viral infections.
    Life Sci. 2025;361:123340.
    >> Share

  7. CHOPRA A, Franko N, Chow EJ
    Navigating neurologic post-COVID-19 conditions in adults: Management strategies for cognitive dysfunction, headaches and neuropathies.
    Life Sci. 2025;362:123374.
    >> Share

    December 2024
  8. OATIS D, Balta C, Herman H, Ciceu A, et al
    The interplay between lung galectins and pro-fibrotic markers in post-COVID-19 fibrogenesis: A pilot study.
    Life Sci. 2024 Dec 19:123326. doi: 10.1016/j.lfs.2024.123326.
    >> Share

    November 2024
  9. HERRING TE, Chopra A, Friedly JL, Bender JA, et al
    Post traumatic stress and sleep disorders in long COVID: Patient management and treatment.
    Life Sci. 2024;357:123081.
    >> Share

  10. ASHRAF MS, Tuli K, Moiz S, Sharma SK, et al
    AMP kinase: A promising therapeutic drug target for post-COVID-19 complications.
    Life Sci. 2024;359:123202.
    >> Share

    October 2024
  11. WANG N, Fan H, Wang Y, Shu C, et al
    The hybrid immunity defined by weaker immune imprinting of people living with HIV has a stronger neutralizing response against Omicron variants. A suggested explanation for fewer symptoms in people living with HIV after SARS-CoV-2 variants breakthroug
    Life Sci. 2024 Oct 29:123197. doi: 10.1016/j.lfs.2024.123197.
    >> Share

  12. MARANGI M, Boughattas S, Benslimane F
    Gut microbiome profile to the level species in diarrheic protozoan-carrier patients in Italy.
    Life Sci. 2024 Oct 25:123182. doi: 10.1016/j.lfs.2024.123182.
    >> Share

  13. YU LC
    Gastrointestinal pathophysiology in long COVID: Exploring roles of microbiota dysbiosis and serotonin dysregulation in post-infectious bowel symptoms.
    Life Sci. 2024;358:123153.
    >> Share

  14. DOS SANTOS L, Favaroni Mendes Salgado Ribeiro LA, Febba Gomes AC, Azinheira Nobrega Cruz N, et al
    ACE and ACE2 activities and polymorphisms assessment: A populational study from Ipaussu (SP, Brazil) during the COVID-19 pandemic.
    Life Sci. 2024;358:123157.
    >> Share

  15. TANG CC, Chang JC, Ho SJ, Liu WD, et al
    Exploring the characteristics and antecedents of clinically significant long COVID: A longitudinal cohort study.
    Life Sci. 2024;357:123114.
    >> Share

    September 2024
  16. KING LR
    Gastrointestinal manifestations of long COVID.
    Life Sci. 2024 Sep 30:123100. doi: 10.1016/j.lfs.2024.123100.
    >> Share

  17. SCHULTZ KR, McGrath S, Keary TA, Meng CK, et al
    A multidisciplinary approach to assessment and management of long COVID cognitive concerns.
    Life Sci. 2024;357:123068.
    >> Share

  18. TUDORAN C, Tudoran M, Abu-Awwad A, Abu-Awwad SA, et al
    Sex-related differences concerning the profile and evolution of cardiovascular complications in patients with post-acute COVID-19 syndrome.
    Life Sci. 2024;356:123044.
    >> Share

    August 2024
  19. VINUTHA M, Sharma UR, Swamy G, Rohini S, et al
    COVID-19-related liver injury: Mechanisms, diagnosis, management; its impact on pre-existing conditions, cancer and liver transplant: A comprehensive review.
    Life Sci. 2024 Aug 28:123022. doi: 10.1016/j.lfs.2024.123022.
    >> Share

  20. BRODE WM, Melamed E
    A practical framework for Long COVID treatment in primary care.
    Life Sci. 2024;354:122977.
    >> Share

  21. VOGEL JM, Pollack B, Spier E, McCorkell L, et al
    Designing and optimizing clinical trials for long COVID.
    Life Sci. 2024 Aug 12:122970. doi: 10.1016/j.lfs.2024.122970.
    >> Share

  22. STRONGIN SR, Stelson E, Soares L, Sukhatme V, et al
    Using real-world data to accelerate the search for long COVID therapies.
    Life Sci. 2024;353:122940.
    >> Share

    July 2024
  23. LI B, Bai J, Xiong Y, Guo D, et al
    Understanding the mechanisms and treatments of long COVID to address future public health risks.
    Life Sci. 2024 Jul 29:122938. doi: 10.1016/j.lfs.2024.122938.
    >> Share

  24. LI X, Ding H, Feng G, Huang Y, et al
    Role of angiotensin converting enzyme in pathogenesis associated with immunity in cardiovascular diseases.
    Life Sci. 2024 Jul 8:122903. doi: 10.1016/j.lfs.2024.122903.
    >> Share

  25. PEREIRA-SILVA GC, Cornelio CKCA, Pacheco G, Rochael NC, et al
    Diminazene aceturate inhibits the SARS-CoV-2 spike protein-induced inflammation involving leukocyte migration and DNA extracellular traps formation.
    Life Sci. 2024 Jul 8:122895. doi: 10.1016/j.lfs.2024.122895.
    >> Share

    June 2024
  26. RAHEEM MA, Rahim MA, Gul I, Reyad-Ul-Ferdous M, et al
    COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations.
    Life Sci. 2024 Jun 24:122861. doi: 10.1016/j.lfs.2024.122861.
    >> Share

  27. ENDO HM, Bandeca SCS, Olchanheski LR, Schemczssen-Graeff Z, et al
    Probiotics and the reduction of SARS-CoV-2 infection through regulation of host cell calcium dynamics.
    Life Sci. 2024;350:122784.
    >> Share

  28. HSIEH MS, Chen MY, Chang YS, Huang CS, et al
    Targeting the Neuropilin-1 receptor with Ovatodiolide and progress in using periodontal ligament organoids for COVID-19 research and therapy.
    Life Sci. 2024 Jun 3:122764. doi: 10.1016/j.lfs.2024.122764.
    >> Share

    May 2024
  29. PETRY J, Weiser T, Griesbaum L, Schroder K, et al
    1.8-cineole prevents platelet activation and aggregation by activating the cAMP pathway via the adenosine A(2A) receptor.
    Life Sci. 2024 May 27:122746. doi: 10.1016/j.lfs.2024.122746.
    >> Share

    April 2024
  30. LI Q, Peng G, Liu H, Wang L, et al
    Molecular mechanisms of secretory autophagy and its potential role in diseases.
    Life Sci. 2024 Apr 23:122653. doi: 10.1016/j.lfs.2024.122653.
    >> Share

    February 2024
  31. YOUSEF M, Rob M, Varghese S, Rao S, et al
    The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
    Life Sci. 2024;342:122535.
    >> Share

    December 2023
  32. PORIA R, Kala D, Nagraik R, Dhir Y, et al
    Vaccine development: Current trends and technologies.
    Life Sci. 2023 Dec 7:122331. doi: 10.1016/j.lfs.2023.122331.
    >> Share

    November 2023
  33. MORA-RODRIGUEZ JM, Sanchez BG, Bort A, Diaz-Yuste A, et al
    Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM).
    Life Sci. 2023;336:122292.
    >> Share

  34. ZEYADA MS, Eraky SM, El-Shishtawy MM
    Trigonelline mitigates bleomycin-induced pulmonary inflammation and fibrosis: Insight into NLRP3 inflammasome and SPHK1/S1P/Hippo signaling modulation.
    Life Sci. 2023 Nov 17:122272. doi: 10.1016/j.lfs.2023.122272.
    >> Share

    October 2023
  35. PETPIROON N, Netkueakul W, Sukrak K, Wang C, et al
    Development of lung tissue models and their applications.
    Life Sci. 2023 Oct 24:122208. doi: 10.1016/j.lfs.2023.122208.
    >> Share

  36. KRASAEWES K, Chaiwarith R, Chattipakorn N, Chattipakorn SC, et al
    Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection.
    Life Sci. 2023;332:122136.
    >> Share

    September 2023
  37. ZHONG HL, Li PZ, Li D, Guan CX, et al
    The role of vasoactive intestinal peptide in pulmonary diseases.
    Life Sci. 2023 Sep 22:122121. doi: 10.1016/j.lfs.2023.122121.
    >> Share

  38. ROSA CP, Belo TCA, Santos NCM, Silva EN, et al
    Reactive oxygen species trigger inflammasome activation after intracellular microbial interaction.
    Life Sci. 2023;331:122076.
    >> Share

    July 2023
  39. LU X, Mao T, Dai Y, Zhu L, et al
    Azithromycin exposure during pregnancy disturbs the fetal development and its characteristic of multi-organ toxicity.
    Life Sci. 2023;329:121985.
    >> Share

  40. ISAZADEH A, Heris JA, Shahabi P, Mohammadinasab R, et al
    Pattern-recognition receptors (PRRs) in SARS-CoV-2.
    Life Sci. 2023;329:121940.
    >> Share

    June 2023
  41. YAZDANPARAST S, Bakhtiyaridovvombaygi M, Mikanik F, Ahmadi R, et al
    Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness.
    Life Sci. 2023 Jun 30:121907. doi: 10.1016/j.lfs.2023.121907.
    >> Share

    May 2023
  42. QUEIROZ-JUNIOR CM, Santos ACPM, Goncalves MR, Brito CB, et al
    Acute coronavirus infection triggers a TNF-dependent osteoporotic phenotype in mice.
    Life Sci. 2023 May 2:121750. doi: 10.1016/j.lfs.2023.121750.
    >> Share

    March 2023
  43. DELDADEH N, Haghighat S, Omidi Z, Sarrami-Foroushani R, et al
    Anti-cancer effect of COVID-19 vaccines in 4T1 mice models.
    Life Sci. 2023 Mar 10:121569. doi: 10.1016/j.lfs.2023.121569.
    >> Share

    February 2023
  44. SHER EK, Cosovic A, Dzidic-Krivic A, Farhat EK, et al
    Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases.
    Life Sci. 2023 Feb 27:121531. doi: 10.1016/j.lfs.2023.121531.
    >> Share

  45. GHORBANINEJAD M, Asadzadeh-Aghdaei H, Baharvand H, Meyfour A, et al
    Intestinal organoids: A versatile platform for modeling gastrointestinal diseases and monitoring epigenetic alterations.
    Life Sci. 2023 Feb 27:121506. doi: 10.1016/j.lfs.2023.121506.
    >> Share

  46. EHTESHAMINIA Y, Jalali SF, Jadidi-Niaragh F, Enderami SE, et al
    Enhancement of immunogenicity and neutralizing responses against SARS-CoV-2 spike protein using the Fc fusion fragment.
    Life Sci. 2023 Feb 23:121525. doi: 10.1016/j.lfs.2023.121525.
    >> Share

    January 2023
  47. SAXENA R, Sharma P, Kumar S, Agrawal N, et al
    Modulation of mitochondria by viral proteins.
    Life Sci. 2023;313:121271.
    >> Share

  48. LIN F, Lin X, Fu B, Xiong Y, et al
    Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development.
    Life Sci. 2023;315:121374.
    >> Share

    December 2022
  49. HUSSEIN RM, Arafa EA, Raheem SA, Mohamed WR, et al
    Thymol protects against bleomycin-induced pulmonary fibrosis via abrogation of oxidative stress, inflammation, and modulation of miR-29a/TGF-beta and PI3K/Akt signaling in mice.
    Life Sci. 2022 Dec 19:121256. doi: 10.1016/j.lfs.2022.121256.
    >> Share

    October 2022
  50. ANTAR SA, Saleh MA, Al-Karmalawy AA
    Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2.
    Life Sci. 2022;309:121048.
    >> Share

    September 2022
  51. ALEKSOVA A, Fluca AL, Gagno G, Pierri A, et al
    Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
    Life Sci. 2022 Sep 29:121018. doi: 10.1016/j.lfs.2022.121018.
    >> Share

  52. HSU PC, Shahed-Al-Mahmud M
    SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response.
    Life Sci. 2022 Sep 20:120981. doi: 10.1016/j.lfs.2022.120981.
    >> Share

  53. BARTOLOMEO CS, Lemes RMR, Morais RL, Pereria GC, et al
    SARS-CoV-2 infection and replication kinetics in different human cell types: The role of autophagy, cellular metabolism and ACE2 expression.
    Life Sci. 2022 Sep 5:120930. doi: 10.1016/j.lfs.2022.120930.
    >> Share

    August 2022
  54. SHARIF-ASKARI FS, Hafezi S, Sharif-Askari NS, Alsayed HAH, et al
    Vitamin D modulates systemic inflammation in patients with severe COVID-19.
    Life Sci. 2022 Aug 23:120909. doi: 10.1016/j.lfs.2022.120909.
    >> Share

  55. HOSSEINZADEH A, Bagherifard A, Koosha F, Amiri S, et al
    Melatonin effect on platelets and coagulation: Implications for a prophylactic indication in COVID-19.
    Life Sci. 2022;307:120866.
    >> Share

    July 2022
  56. ALI MA, El-Tahan RA, Kamel MA, Matar NA, et al
    The diabetogenic effects of chronic supplementation of vitamin C or E in rats: Interplay between liver and adipose tissues transcriptional machinery of lipid metabolism.
    Life Sci. 2022 Jul 18:120812. doi: 10.1016/j.lfs.2022.120812.
    >> Share

  57. MALEKINEJAD Z, Baghbanzadeh A, Nakhlband A, Baradaran B, et al
    Recent clinical findings on the role of kinase inhibitors in COVID-19 management.
    Life Sci. 2022 Jul 13:120809. doi: 10.1016/j.lfs.2022.120809.
    >> Share

  58. MAZUMDER S, Bindu S, De R, Debsharma S, et al
    Emerging role of mitochondrial DAMPs, aberrant mitochondrial dynamics and anomalous mitophagy in gut mucosal pathogenesis.
    Life Sci. 2022 Jul 1:120753. doi: 10.1016/j.lfs.2022.120753.
    >> Share

  59. PANDA M, Kalita E, Singh S, Kumar K, et al
    MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies.
    Life Sci. 2022 Jul 1:120761. doi: 10.1016/j.lfs.2022.120761.
    >> Share

    June 2022
  60. GUPTA A, Jayakumar MN, Saleh MA, Kannan M, et al
    SARS-CoV-2-infection induced growth factors play differential roles in COVID-19 pathogenesis.
    Life Sci. 2022 Jun 11:120703. doi: 10.1016/j.lfs.2022.120703.
    >> Share

    May 2022
  61. PATIL PJ, Sutar SS, Usman M, Patil DN, et al
    Exploring bioactive peptides as potential therapeutic and biotechnology treasures: A contemporary perspective.
    Life Sci. 2022;301:120637.
    >> Share

  62. FERNANDES MF, Chan JZ, Hung CCJ, Tomczewski MV, et al
    Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein.
    Life Sci. 2022;301:120624.
    >> Share

  63. HUANG DY, Wang GM, Ke ZR, Zhou Y, et al
    Megakaryocytes in pulmonary diseases.
    Life Sci. 2022 May 1:120602. doi: 10.1016/j.lfs.2022.120602.
    >> Share

    April 2022
  64. YOUNG LJ, Antwi-Boasiako S, Ferrall J, Wold LE, et al
    Genetic and non-genetic risk factors associated with atrial fibrillation.
    Life Sci. 2022;299:120529.
    >> Share

    March 2022
  65. MAZIDIMORADI A, Alemzadeh E, Alemzadeh E, Salehiniya H, et al
    The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review.
    Life Sci. 2022 Mar 28:120489. doi: 10.1016/j.lfs.2022.120489.
    >> Share

  66. NADEALI Z, Rezaei FM, Aria H, Nikpour P, et al
    Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19.
    Life Sci. 2022 Mar 11:120482. doi: 10.1016/j.lfs.2022.120482.
    >> Share

  67. MENENDEZ SG, Martin Gimenez VM, Holick MF, Barrantes FJ, et al
    COVID-19 and neurological sequelae: Vitamin D as a possible neuroprotective and/or neuroreparative agent.
    Life Sci. 2022;297:120464.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016